Skip to main content
. 2014 May 29;3(1):204–214. doi: 10.1016/j.stemcr.2014.04.018

Table 1.

Increase of IFNs and ISG Expression in Stem Cell-Derived Hepatocytes after Treatment with IL-29 or HCV

Gene Symbol RefSeq Fold Increase
Gene Description
IL-29 Treatment HCV Treatment
IFIT1 NM_001548 2,488.73 4.64 IFN-induced protein with tetratricopeptide repeats 1
IFI27 NM_005532 927.55 5.91 alpha-inducible protein 27
IFI44 NM_006417 389.86 6.64 IFN-induced protein 44
IFI44L NM_006820 216.25 2.54 IFN-induced protein 44-like
IFIT2 NM_001547 152.75 3.41 IFN-induced protein with tetratricopeptide repeats 2
IFI6 NM_002038 111.52 5.12 IFN, alpha-inducible protein 6
CXCL10 NM_001565 110.63 4.32 chemokine (C-X-C motif) ligand 10
OAS1 NM_002534 88.16 5.73 2′-5′-oligoadenylate synthetase 1, 40/46 kDa
ISG15 NM_005101 52.36 4.35 ISG15 ubiquitin-like modifier
IFIH1 NM_022168 51.89 4.19 IFN induced with helicase C domain 1
IFITM1 NM_003641 20.27 6.29 IFN-induced transmembrane protein 1 (9–27)
IRF7 NM_001572 18.56 12.51 IFN regulatory factor 7
IFNA8 NM_002170 16.90 6.49 IFN, alpha 8
IFI35 NM_005533 11.27 5.65 IFN-induced protein 35
MX1 NM_002462 11.26 4.66 myxovirus (influenza virus) resistance 1, IFN-inducible protein p78 (mouse)
IL-29 NM_172140 10.99 7.10 IL-29 (IFN, lambda 1)

See also Table S3.